Dexcom made a significant design change to a component used in its sensors and did not adequately validate the change, ...

DexCom plans to launch its 15-day G7 sensor in the second half of 2025, pending FDA approval. A longer wear time may boost ...

DexCom DXCM received a warning letter from the FDA on March 4, 2025, following inspections of its San Diego and Mesa facilities in 2024. The FDA cited deficiencies in the company’s manufacturing ...

Dexcom’s investigational 15-day continuous glucose monitor has a lower mean absolute relative difference than the current ...

Jake Leach caught up with MedTech Dive during the ATTD conference to discuss new data on the company’s glucose monitors and ...

DexCom DXCM received a warning letter ... Abbott's FreeStyle Libre continuous glucose monitoring system (CGM) has seen significant growth, with sales surpassing $1.8 billion in the fourth quarter ...

Abbott, Dexcom, Insulet, Medtronic and others are developing next-gen sensors, pumps and algorithms for type 2 diabetes ...

Dexcom advanced the launch of Stelo, its over-the-counter product for non-insulin type 2 diabetes, pre-diabetes, and ...

A supply-chain snag due to regulatory action may hit DexCom’s product availability, thereby losing in competition, which may lead to a DME share loss. Roche's Accu-Chek SmartGuide, an AI-enabled CGM ...